UroGen Pharma Ltd. (NASDAQ:URGN) is one of the best small-cap biotech stocks to buy according to analysts.

Biotech stocks have performed well this year. The SPDR S&P Biotech ETF -- an industry benchmark -- is up 21% this year. Two ...

Vertex Pharmaceuticals (NASDAQ: VRTX) has not performed well for most of the year, and the company's latest quarterly update ...

Biotech Insiders Are Spending Billions. Trump Favors Less Oversight. One Biotech ETF Could Ride the Surge. M&A activity is ...

Shares of mid-cap oncology specialist Exelixis are worth about $39 each right now. The biotech generates steady revenue and profits thanks to an important cancer drug. It's developing other products ...

Sana Biotechnology Inc. (NASDAQ: SANA) is a must-buy penny stock according to analysts. On November 7, Bank of America ...

With the stock market charging higher in 2025, a group of small-cap stocks has presented unique and focused opportunities for investors. These companies have more than doubled in the past few ...

The best healthcare stocks from Goldman Sachs' list that are also Quant Strong Buys have attractive valuations and forward ...

The company's annualized recurring revenue run rate jumped 30% year over year in Q3 to $2 billion. Its gross payment volume ...

Bullish investors looking to buy stocks in November and beyond might want to consider best-in-class cheap stocks trading for ...

Galecto stock skyrockets after announcing Damora Therapeutics acquisition. Here’s why GLTO shares are super unattractive to ...

Krystal Biotech drives Vyjuvek growth, premium margins, global expansion, a $1B goal, and pipeline data ahead with a $219.50 ...